79
Adrenocortical Adrenocortical disorders disorders By By AbdAlAziz AbdAlAziz AbdAllah, MD AbdAllah, MD

Adrenocortical Disorders

Embed Size (px)

DESCRIPTION

adrenak cortex disorders

Citation preview

Page 1: Adrenocortical Disorders

Adrenocortical Adrenocortical disordersdisorders

ByBy

AbdAlAziz AbdAllah, AbdAlAziz AbdAllah, MDMD

Page 2: Adrenocortical Disorders

The adrenal gland is divided into two The adrenal gland is divided into two parts, adrenal cortex and medullaparts, adrenal cortex and medulla..

The adrenal cortex secretes androgen, The adrenal cortex secretes androgen, mineralocorticoids (eg, aldosteron) and mineralocorticoids (eg, aldosteron) and glucocorticoids (eg, crtisol)glucocorticoids (eg, crtisol)..

The adrenal medulla secretes The adrenal medulla secretes catecholamines (eg, epinephrine, catecholamines (eg, epinephrine, norepinephrine, dopamine)norepinephrine, dopamine)..

Page 3: Adrenocortical Disorders

Aldosteron is primarily involved with Aldosteron is primarily involved with fluid and electrolyte balancefluid and electrolyte balance..

Aldosteron secretion causes sodium Aldosteron secretion causes sodium reabsorption in the distal renal reabsorption in the distal renal tubule in exchange for potassium tubule in exchange for potassium and hydrogen ionsand hydrogen ions..

The net effects are, fluid retention, The net effects are, fluid retention, decrease in plasma potassium and decrease in plasma potassium and metabolic alkalosismetabolic alkalosis..

Page 4: Adrenocortical Disorders

Aldosteron secretion is stimulated byAldosteron secretion is stimulated by;;

--Renin-angiotensin systemRenin-angiotensin system..

--ACTHACTH..

--HyperkalemiaHyperkalemia..

--HypovolemiaHypovolemia . .

--HypotensionHypotension . .

--congestive heart failurecongestive heart failure..

--SurgerySurgery..

Page 5: Adrenocortical Disorders

Glucocorticoids are essential for life and have Glucocorticoids are essential for life and have mutiple pysiological effectsmutiple pysiological effects..

Metabolic actions include enhanced Metabolic actions include enhanced gluconeogenesis and inhibition of peripheral gluconeogenesis and inhibition of peripheral glucose utilizationglucose utilization..

Glucocorticoids are required for vascular and Glucocorticoids are required for vascular and bronchial smooth muscle to be responsive to bronchial smooth muscle to be responsive to catecholaminescatecholamines..

Glucocorticoids are structurly related to Glucocorticoids are structurly related to aldosteron, so they have aldosteron like actionaldosteron, so they have aldosteron like action..

Page 6: Adrenocortical Disorders

ACTH is the principal regulator of ACTH is the principal regulator of Glucocorticoids secretionGlucocorticoids secretion..

Secretion of ACTH and glucocorticoids Secretion of ACTH and glucocorticoids exhibit a diurnal rhythm, stimulated by exhibit a diurnal rhythm, stimulated by stress and inhibited by circulating stress and inhibited by circulating glucocorticoidsglucocorticoids..

Endogenous production of cortisol Endogenous production of cortisol averages 20 mg \ dayaverages 20 mg \ day..

Page 7: Adrenocortical Disorders

Mineralocorticoid excessMineralocorticoid excess

I- 1ry hyper-aldosteronism (I- 1ry hyper-aldosteronism (Conn Conn syndrome)syndrome)::

Conn syndrome is characterized by increased Conn syndrome is characterized by increased aldosterone secretion from the adrenal glands, it aldosterone secretion from the adrenal glands, it was first described in 1955 by J. W. Conn in a was first described in 1955 by J. W. Conn in a patient who had an aldosterone-producing patient who had an aldosterone-producing

adenomaadenoma..

Page 8: Adrenocortical Disorders

PathophysiologyPathophysiologyPrimary hyperaldosteronism is caused by Primary hyperaldosteronism is caused by

increased aldosterone excretion from the increased aldosterone excretion from the adrenals, which results primarily from 2 major adrenals, which results primarily from 2 major subtypessubtypes : :

((11 ) )unilateral aldosterone-producing adenoma , unilateral aldosterone-producing adenoma , Conn syndrome, (50-60% of cases)Conn syndrome, (50-60% of cases)

((22 ) )idiopathic hyperaldosteronism (IHA) or bilateral idiopathic hyperaldosteronism (IHA) or bilateral adrenal hyperplasia (40-50% of cases)adrenal hyperplasia (40-50% of cases) . .

((33 ) )Rarely, aldosterone can be secreted by Rarely, aldosterone can be secreted by adrenocortical carcinomas and ovarian tumorsadrenocortical carcinomas and ovarian tumors..

Page 9: Adrenocortical Disorders

Aldosterone, by inducing renal Aldosterone, by inducing renal distal tubular reabsorption of distal tubular reabsorption of sodium, enhances secretion of sodium, enhances secretion of potassium and hydrogen ions, potassium and hydrogen ions, causing hypernatremia, causing hypernatremia, hypokalemia, and metabolic hypokalemia, and metabolic alkalosisalkalosis..

Page 10: Adrenocortical Disorders

FrequencyFrequency::Prevalence for Conn syndrome; 0.05-2% of the Prevalence for Conn syndrome; 0.05-2% of the

populationpopulation..

Mortality/MorbidityMortality/Morbidity::The morbidity and mortality associated with The morbidity and mortality associated with

Conn syndrome, are primarily related toConn syndrome, are primarily related to ; ;11 - -Hypertension, especially if left untreated for Hypertension, especially if left untreated for

many years, can lead to many complications, many years, can lead to many complications, including heart disease )eg, coronary artery including heart disease )eg, coronary artery disease, congestive heart failure(, stroke, and disease, congestive heart failure(, stroke, and intracerebral hemorrhage )with very high blood intracerebral hemorrhage )with very high blood pressure(pressure(..

Page 11: Adrenocortical Disorders

22--Hypokalemia, especially if severe, causes Hypokalemia, especially if severe, causes cardiac arrhythmias, which cancardiac arrhythmias, which can be fatal be fatal

AgeAgePeak incidence occurs in the third to sixth Peak incidence occurs in the third to sixth

decades of lifedecades of life..

SexSexPrimary hyperaldosteronism is twice as common Primary hyperaldosteronism is twice as common

in women as in menin women as in men..

Page 12: Adrenocortical Disorders

II- 2ry hyperaldosteronismII- 2ry hyperaldosteronism::

There is increased renin-angiotensin with There is increased renin-angiotensin with increased aldosteron secretionincreased aldosteron secretion;;

--CHFCHF--Liver cirrhosis and ascitisLiver cirrhosis and ascitis

--Nephrotic syndromeNephrotic syndrome--Renal artery stenosisRenal artery stenosis

Page 13: Adrenocortical Disorders

Clinical manifestationsClinical manifestations--HypertensionHypertension ; ;

--HypokalemiaHypokalemia;; patients with severe hypokalemia report fatigue, patients with severe hypokalemia report fatigue,

muscle weakness, cramping, headaches, and muscle weakness, cramping, headaches, and palpitations. They can also have polydipsia and palpitations. They can also have polydipsia and polyuria from hypokalemia-induced nephrogenic polyuria from hypokalemia-induced nephrogenic diabetes insipidusdiabetes insipidus..

Page 14: Adrenocortical Disorders

--Metabolic alkalosisMetabolic alkalosis ; ;will lower ionized calcium levels and can will lower ionized calcium levels and can

cause tetanycause tetany..InvestigationsInvestigations::

Laboratory StudiesLaboratory Studies--hypernatremiahypernatremia

--Hypokalemia; normokalemia does not Hypokalemia; normokalemia does not exclude primary hyperaldosteronism. Several exclude primary hyperaldosteronism. Several studies have shown that 7-38% of patients studies have shown that 7-38% of patients with primary hyperaldosteronism have with primary hyperaldosteronism have normal baseline serum levels of potassiumnormal baseline serum levels of potassium

Page 15: Adrenocortical Disorders

--metabolic alkalosismetabolic alkalosis--Renin levels are suppressed to less than 1 Renin levels are suppressed to less than 1

ng/mL/h in patients with primary ng/mL/h in patients with primary hyperaldosteronismhyperaldosteronism..

--A 24-hour aldosterone excretion rate of A 24-hour aldosterone excretion rate of greater than 14 ug is diagnostic of primary greater than 14 ug is diagnostic of primary hyperaldosteronismhyperaldosteronism

Page 16: Adrenocortical Disorders

Imaging StudiesImaging Studies

--CT scanningCT scanning--MRIMRI

Page 17: Adrenocortical Disorders

TreatmentTreatment

MedicalMedical medical therapy is used preoperatively to medical therapy is used preoperatively to

prevent the morbidity and mortality associated prevent the morbidity and mortality associated with hypertension and hypokalemia, thus with hypertension and hypokalemia, thus

decreasing surgical riskdecreasing surgical risk.. -- Sodium-restricted diet )<80 mEq or <2 g of Sodium-restricted diet )<80 mEq or <2 g of

sodium per daysodium per day..--Potassium-sparing agent )first-step agent( such Potassium-sparing agent )first-step agent( such

as spironolactoneas spironolactone100 mg initially, increase to 100 mg initially, increase to 400 mg/d for control of blood pressure400 mg/d for control of blood pressure..

Page 18: Adrenocortical Disorders

--Potassium supplementation should not be Potassium supplementation should not be routinely administered with spironolactone routinely administered with spironolactone because of the potential for the development of because of the potential for the development of hyperkalemiahyperkalemia..

--Second-step agents include thiazides diuretics, Second-step agents include thiazides diuretics, ACE inhibitors, calcium channel antagonists, ACE inhibitors, calcium channel antagonists, and angiotensin II blockersand angiotensin II blockers..

Page 19: Adrenocortical Disorders

Surgical CareSurgical Care

Surgery is the main therapy for Conn Surgery is the main therapy for Conn syndrome. A laparoscopic adrenalectomy syndrome. A laparoscopic adrenalectomy is favored, when possibleis favored, when possible

Page 20: Adrenocortical Disorders

Anesthetic considerationsAnesthetic considerations

Preoperative correction of hypertension, CHF Preoperative correction of hypertension, CHF and volume and electrolytes imbalance specially and volume and electrolytes imbalance specially potassium is mandatorypotassium is mandatory..

Page 21: Adrenocortical Disorders

Mineralocorticoid deficiencyMineralocorticoid deficiency

--Hypo-aldosteronismHypo-aldosteronism Atrophy or destruction of both adrenal Atrophy or destruction of both adrenal

glands results in a combined deficiency of glands results in a combined deficiency of Mineralocorticoid and glucocorticoid Mineralocorticoid and glucocorticoid

( addison disease)( addison disease). . --Isolated Mineralocorticoid deficiencyIsolated Mineralocorticoid deficiency;;

--Unilateral adrenalectomyUnilateral adrenalectomy--DM -Heparine therapyDM -Heparine therapy

--congenitalcongenital

Page 22: Adrenocortical Disorders

C\PC\P

**Hypotension; due to hypovolemiaHypotension; due to hypovolemia**Metabolic acidosisMetabolic acidosis

**Hyperkalemia; any increase in s. Hyperkalemia; any increase in s. potassium without renal impairment, potassium without renal impairment, hypoaldosteronism should be consideredhypoaldosteronism should be considered..

**hyponatremiahyponatremia

Page 23: Adrenocortical Disorders

Anesthetic managementAnesthetic management Preoperative preparation includesPreoperative preparation includes;;

**correction of fluid and electrolyte correction of fluid and electrolyte imbalanceimbalance

**exogenous mineralocorticoid, exogenous mineralocorticoid, fludrocortison 0.1-0.3 mg\ dayfludrocortison 0.1-0.3 mg\ day..

Page 24: Adrenocortical Disorders

Glucocorticoid excessGlucocorticoid excess

Cushing syndromeCushing syndrome

Cushing syndrome is caused by prolonged Cushing syndrome is caused by prolonged exposure to elevated levels of either exposure to elevated levels of either endogenous glucocorticoids or exogenous endogenous glucocorticoids or exogenous glucocorticoidsglucocorticoids

Page 25: Adrenocortical Disorders

CausesCauses::

--Exogenous steroid administrationExogenous steroid administrationSymptoms of glucocorticoid excess generally Symptoms of glucocorticoid excess generally

occur with the administration of oral steroids; occur with the administration of oral steroids; however, occasionally injections of steroids into however, occasionally injections of steroids into joints and the use of steroid inhalers can cause joints and the use of steroid inhalers can cause Cushing syndromeCushing syndrome..

Page 26: Adrenocortical Disorders

Patients at risk to develop cushing syndrome Patients at risk to develop cushing syndrome includesincludes::

--rheumatological, pulmonary, neurological, and rheumatological, pulmonary, neurological, and nephrologic diseases that respond to steroid nephrologic diseases that respond to steroid therapytherapy..

--Patients who have undergone organ transplants Patients who have undergone organ transplants due to exogenous steroids required as part of due to exogenous steroids required as part of graft antirejection medication regimensgraft antirejection medication regimens..

Page 27: Adrenocortical Disorders

Endogenous glucocorticoid administrationEndogenous glucocorticoid administration

--ACTH-producing pituitary adenoma ( Cushing ACTH-producing pituitary adenoma ( Cushing disease)disease)..

--Primary adrenal lesions; Overproduction of Primary adrenal lesions; Overproduction of glucocorticoids may be due to an adrenal glucocorticoids may be due to an adrenal adenoma, adrenal carcinoma, or macronodular adenoma, adrenal carcinoma, or macronodular or micronodular adrenal hyperplasiaor micronodular adrenal hyperplasia..

Page 28: Adrenocortical Disorders

--Ectopic ACTH is sometimes secreted by oat Ectopic ACTH is sometimes secreted by oat cell or small-cell lung tumors or by carcinoid cell or small-cell lung tumors or by carcinoid tumorstumors

Page 29: Adrenocortical Disorders

FrequencyFrequencyMost cases of Cushing syndrome are due to Most cases of Cushing syndrome are due to

exogenous glucocorticoids. Endogenous exogenous glucocorticoids. Endogenous Cushing syndrome has been estimated at 13 Cushing syndrome has been estimated at 13 cases per million individualscases per million individuals..

AgeAgeThe peak incidence of Cushing syndrome due to The peak incidence of Cushing syndrome due to

either an adrenal or pituitary adenoma is in either an adrenal or pituitary adenoma is in persons aged 25-40 yearspersons aged 25-40 years

Ectopic ACTH production due to lung cancer Ectopic ACTH production due to lung cancer occurs later in lifeoccurs later in life

Page 30: Adrenocortical Disorders

SexSex

The female-to-male incidence ratio is The female-to-male incidence ratio is approximately 5:1 for Cushing syndrome due to approximately 5:1 for Cushing syndrome due to an adrenal or pituitary tumoran adrenal or pituitary tumor

Page 31: Adrenocortical Disorders

Mortality/MorbidityMortality/Morbidity**Morbidity and mortality associated with Cushing Morbidity and mortality associated with Cushing

syndrome are related primarily to the effects of syndrome are related primarily to the effects of excess glucocorticoids. However, a large primary excess glucocorticoids. However, a large primary pituitary tumor may cause panhypopituitarism and pituitary tumor may cause panhypopituitarism and visual lossvisual loss..

**adrenocortical carcinomas are associated with a adrenocortical carcinomas are associated with a 5-year survival rate of 30% or less5-year survival rate of 30% or less..

   

Page 32: Adrenocortical Disorders

* *multiple medical problems, including multiple medical problems, including hypertension, obesity, osteoporosis, fractures, hypertension, obesity, osteoporosis, fractures, impaired immune function, impaired wound impaired immune function, impaired wound

healing, glucose intolerance, and psychosishealing, glucose intolerance, and psychosis . .

* *adrenal crisisadrenal crisis

Page 33: Adrenocortical Disorders

C\pC\p

ObesityObesity --moon faciesmoon facies--buffalo humpbuffalo hump

--Central obesity, increased waist-to-hip ratio Central obesity, increased waist-to-hip ratio greater than 1 in men and 0.8 in womengreater than 1 in men and 0.8 in women

Page 34: Adrenocortical Disorders

SkinSkin Facial plethoraFacial plethora

abdominal striaeabdominal striae lanugo facial hairlanugo facial hair

Hirsutism and Steroid acneHirsutism and Steroid acne

Page 35: Adrenocortical Disorders

Cardiovascular and renalCardiovascular and renal Hypertension and possibly edema may be Hypertension and possibly edema may be

present due to cortisol activation of the present due to cortisol activation of the mineralocorticoid receptor leading to sodium and mineralocorticoid receptor leading to sodium and water retentionwater retention

GastroenterologicGastroenterologic Peptic ulceration may occur with or without Peptic ulceration may occur with or without

symptomssymptoms . .

Page 36: Adrenocortical Disorders

endocrineendocrine Galactorrhea and menstrual disturbancesGalactorrhea and menstrual disturbances

decreased libido and impotence in mendecreased libido and impotence in men..

Skeletal/muscularSkeletal/muscular Proximal muscle weaknessProximal muscle weakness

Osteoporosis and osteopeniaOsteoporosis and osteopeniaAvascular necrosis of the hipAvascular necrosis of the hip

Page 37: Adrenocortical Disorders

NeuropsychologicalNeuropsychological

emotional liability, fatigue, and depressionemotional liability, fatigue, and depressionVisual-field defects, often bitemporal, and Visual-field defects, often bitemporal, and

blurred visionblurred vision

Adrenal crisisAdrenal crisis

Page 38: Adrenocortical Disorders

InvestigationsInvestigations

Laboratory StudiesLaboratory StudiesHyperglycemiaHyperglycemia

Hypokalemic metabolic alkalosisHypokalemic metabolic alkalosis

Biochemical evaluation of Cushing syndromeBiochemical evaluation of Cushing syndrome::11--Urinary free cortisol excretion over 150 ug\ Urinary free cortisol excretion over 150 ug\

dayday..

Page 39: Adrenocortical Disorders

22 - -dexamethasone suppression test; dexamethasone suppression test; glucocorticoids inhibit secretion of hypothalamic glucocorticoids inhibit secretion of hypothalamic CRH and pituitary ACTH but do not directly CRH and pituitary ACTH but do not directly affect adrenal cortisol production. The overnight affect adrenal cortisol production. The overnight 1-mg dexamethasone suppression test requires 1-mg dexamethasone suppression test requires administration of 1 mg of dexamethasone at administration of 1 mg of dexamethasone at 11 PM with subsequent measurement of cortisol 11 PM with subsequent measurement of cortisol level at 8 am.level at 8 am.44 In healthy individuals, the serum In healthy individuals, the serum cortisol level should be less than 2-3 ug/dLcortisol level should be less than 2-3 ug/dL..

Page 40: Adrenocortical Disorders

33--loss of circadian rhythm of cortisol secretionloss of circadian rhythm of cortisol secretionNormal values, 10-25 ug\ml in the morning, 2-10 Normal values, 10-25 ug\ml in the morning, 2-10

ug\ml in the evening, elevated serum cortisol at ug\ml in the evening, elevated serum cortisol at 11 PM can be an early finding11 PM can be an early finding..

Recently, measuring salivary cortisol level has Recently, measuring salivary cortisol level has gained interest, as it is a simple and convenient gained interest, as it is a simple and convenient way of obtaining a nighttime sampl. levels less way of obtaining a nighttime sampl. levels less than 1.3-1.5 ng/mL exclude Cushing syndromethan 1.3-1.5 ng/mL exclude Cushing syndrome..

Page 41: Adrenocortical Disorders

44 - -A plasma ACTH of less than 5 pg/mL is A plasma ACTH of less than 5 pg/mL is suggestive of a primary adrenal tumor. An ACTH suggestive of a primary adrenal tumor. An ACTH level greater than 10-20 pg/mL is consistent with level greater than 10-20 pg/mL is consistent with ACTH-dependent Cushing syndromeACTH-dependent Cushing syndrome..

Page 42: Adrenocortical Disorders

Imaging studiesImaging studiesCT or MRI brain and abdomenCT or MRI brain and abdomen

Page 43: Adrenocortical Disorders

TreatmentTreatment**Hypopysectomy for pituitary tumors, or Hypopysectomy for pituitary tumors, or

adrenalectomy for adrenal tumorsadrenalectomy for adrenal tumors..

**Pituitary irradiation is employed when Pituitary irradiation is employed when transsphenoidal surgery is not successful or not transsphenoidal surgery is not successful or not possiblepossible

**Patients with endogenous Cushing syndrome Patients with endogenous Cushing syndrome who undergo resection of pituitary, adrenal, or who undergo resection of pituitary, adrenal, or ectopic tumors should receive stress doses of ectopic tumors should receive stress doses of glucocorticoid in the intraoperative and glucocorticoid in the intraoperative and immediate postoperative periodimmediate postoperative period

Page 44: Adrenocortical Disorders

**lifelong glucocorticoid and mineralocorticoid lifelong glucocorticoid and mineralocorticoid replacement is necessary in those patients who replacement is necessary in those patients who undergo bilateral adrenalectomyundergo bilateral adrenalectomy..

Page 45: Adrenocortical Disorders

Anesthetic considerationsAnesthetic considerations

Preoperative managementPreoperative managementFrom the C\P those pt. Tend to be volume From the C\P those pt. Tend to be volume

overloaded, hypertensive and hypokalemic, so overloaded, hypertensive and hypokalemic, so Preoperative correction of these factors are Preoperative correction of these factors are essential by potassium and spironolactoneessential by potassium and spironolactone..

Page 46: Adrenocortical Disorders

IntaoperativeIntaoperative Patients with osteoprosis are at risk for fracture Patients with osteoprosis are at risk for fracture

during positioningduring positioning..Preoperative weakness may indicate an Preoperative weakness may indicate an

increased sensitivity to muscle relaxantsincreased sensitivity to muscle relaxants..

Page 47: Adrenocortical Disorders

Supplemental steroids are indicated forSupplemental steroids are indicated for;;--patients with Cushing syndrome due to patients with Cushing syndrome due to

exogenous glucocorticoidsexogenous glucocorticoids

--patients undergoing adrenalectomypatients undergoing adrenalectomyDose; I.V. hydrocortisone succinate 100 mg Dose; I.V. hydrocortisone succinate 100 mg

every 8 h beginning the evening before surgery every 8 h beginning the evening before surgery or on the morning of surgeryor on the morning of surgery..

Other complications of adrenalectomy include Other complications of adrenalectomy include significant blood loss and unintentional significant blood loss and unintentional

pneumothoraxpneumothorax..

Page 48: Adrenocortical Disorders

Pseudo-Cushing SyndromePseudo-Cushing Syndrome

In 1976, Smalls and associates described 3 In 1976, Smalls and associates described 3 alcoholic patients who had the physical and alcoholic patients who had the physical and biochemical abnormalities of Cushing syndrome. biochemical abnormalities of Cushing syndrome. Most of the abnormalities disappeared with 1-3 Most of the abnormalities disappeared with 1-3 weeks of alcohol abstinence. About 30 cases weeks of alcohol abstinence. About 30 cases

have been reportedhave been reported..

Page 49: Adrenocortical Disorders

PathophysiologyPathophysiologyThe mechanism remains unclear. Most evidence The mechanism remains unclear. Most evidence

suggests central stimulation of a corticotropin-suggests central stimulation of a corticotropin-releasing hormone, either at the hypothalamic or releasing hormone, either at the hypothalamic or

suprahypothalamic levelsuprahypothalamic level . .Persistence of abnormalities may lead to Persistence of abnormalities may lead to

complications such as hypertension, glucose complications such as hypertension, glucose intolerance, diabetes mellitus, and osteoporosisintolerance, diabetes mellitus, and osteoporosis..

The most important part of the history is the The most important part of the history is the extent and duration of alcohol abuseextent and duration of alcohol abuse..

Page 50: Adrenocortical Disorders

Glucocorticoid deficiencyGlucocorticoid deficiency

Addison DiseaseAddison DiseaseThomas Addison first described the clinical Thomas Addison first described the clinical presentation of primary adrenocortical presentation of primary adrenocortical insufficiency )Addison disease( in 1855 in his insufficiency )Addison disease( in 1855 in his classic paper, On the Constitutional and Local classic paper, On the Constitutional and Local Effects of Disease of the Supra-Renal CapsulesEffects of Disease of the Supra-Renal Capsules..

Page 51: Adrenocortical Disorders

PathophysiologyPathophysiology

Addison disease is adrenocortical insufficiency due Addison disease is adrenocortical insufficiency due to the destruction or dysfunction of the entire to the destruction or dysfunction of the entire adrenal cortex. It affects glucocorticoid and adrenal cortex. It affects glucocorticoid and mineralocorticoid function. The onset of disease mineralocorticoid function. The onset of disease usually occurs when 90% or more of both usually occurs when 90% or more of both adrenal cortices are dysfunctional or destroyedadrenal cortices are dysfunctional or destroyed..

FrequencyFrequency

The prevalence of Addison disease is 40-60 cases The prevalence of Addison disease is 40-60 cases per 1 million populationper 1 million population..

Page 52: Adrenocortical Disorders

CausesCauses11 - -idiopathic autoimmune adrenocortical idiopathic autoimmune adrenocortical

insufficiencyinsufficiency..

22 - -Chronic granulomatous diseases; TB, Chronic granulomatous diseases; TB, sarcoidosis, histoplasmosissarcoidosis, histoplasmosis . .

33 - -Hematologic malignancies; as HodgkinHematologic malignancies; as Hodgkin

and non-Hodgkin lymphoma and leukemiaand non-Hodgkin lymphoma and leukemia . .

Page 53: Adrenocortical Disorders

44 - -Metastatic malignant disease; as metastatic Metastatic malignant disease; as metastatic cancer of the lung, breast, colon or renal cell cancer of the lung, breast, colon or renal cell carcinomacarcinoma..

55--Infiltrative metabolic disorders; Amyloidosis Infiltrative metabolic disorders; Amyloidosis and hemochromatosisand hemochromatosis..

66 - -AIDSAIDS..

Page 54: Adrenocortical Disorders

AgeAgeThe most common age at presentation in adults The most common age at presentation in adults

is 30-50 yearsis 30-50 years..

SexSexIdiopathic autoimmune Addison disease tends to Idiopathic autoimmune Addison disease tends to

be more common in females and childrenbe more common in females and children..

Page 55: Adrenocortical Disorders

Secondary adrenal insufficiency is a result Secondary adrenal insufficiency is a result of inadequate ACTH secretion by the of inadequate ACTH secretion by the pituitary, the most common cause of pituitary, the most common cause of secondary adrenal insufficiency is secondary adrenal insufficiency is iatrogenic, the result of the administration iatrogenic, the result of the administration

of exogenous glucocorticoidsof exogenous glucocorticoids . .

Page 56: Adrenocortical Disorders

C\PC\PPatients usually present with features of both Patients usually present with features of both

glucocorticoid and mineralocorticoid deficiency. glucocorticoid and mineralocorticoid deficiency. The predominant symptoms vary depending on The predominant symptoms vary depending on the duration of diseasethe duration of disease..

--Hyperpigmentation of the skin and mucous Hyperpigmentation of the skin and mucous membranes due to high ACTHmembranes due to high ACTH..

- -vitiligo, which most often is seen in idiopathic vitiligo, which most often is seen in idiopathic autoimmune Addison diseaseautoimmune Addison disease..

Page 57: Adrenocortical Disorders

--clinical manifestations due to aldosteron clinical manifestations due to aldosteron deficiency; hyponatremia, hypovolemia, deficiency; hyponatremia, hypovolemia, hypotension, hyperkalemia and metabolic hypotension, hyperkalemia and metabolic acidosisacidosis

Page 58: Adrenocortical Disorders

--clinical manifestations due to cortisol deficiency; clinical manifestations due to cortisol deficiency; weakness, fatigue, hypoglycemia, hypotension, weakness, fatigue, hypoglycemia, hypotension, and weight lossand weight loss..

--Prominent gastrointestinal symptoms may include Prominent gastrointestinal symptoms may include nausea, vomiting, and occasional diarrheanausea, vomiting, and occasional diarrhea..

- -Patients with Patients with secondary adrenal secondary adrenal insufficiencyinsufficiency have a history of tacking cortisol have a history of tacking cortisol..

- -acute adrenal crisisacute adrenal crisis

Page 59: Adrenocortical Disorders

InvestigationsInvestigations

Laboratory StudiesLaboratory Studies--ACTH stimulation test; In patients with Addison ACTH stimulation test; In patients with Addison

disease, both cortisol and aldosterone show disease, both cortisol and aldosterone show minimal or no change in response to ACTHminimal or no change in response to ACTH..

--hyponatremiahyponatremia HyperkalemiaHyperkalemia

metabolic acidosismetabolic acidosis

Page 60: Adrenocortical Disorders

--elevated )BUN( and creatinine due to the elevated )BUN( and creatinine due to the hypovolemia with decreased glomerular hypovolemia with decreased glomerular filtration ratefiltration rate..

--HypoglycemiaHypoglycemia

--adrenal autoantibodies may be presentadrenal autoantibodies may be present

Page 61: Adrenocortical Disorders

Imaging studyImaging study

Chest x-ray TBChest x-ray TB

CT abdomenCT abdomen

Page 62: Adrenocortical Disorders

TreatmentTreatment The goals of pharmacotherapy are to reduce morbidity The goals of pharmacotherapy are to reduce morbidity

and to prevent complications e.g adrenal crisisand to prevent complications e.g adrenal crisis;;11 - -ccorticosteroid: orticosteroid: Prednisone Prednisone 5-7.5 mg PO qd in am or 5 5-7.5 mg PO qd in am or 5

mg PO qd in am and 2.5 mg PO qd at 4-5 pmmg PO qd in am and 2.5 mg PO qd at 4-5 pm..

22 - -mineralocorticoid: mineralocorticoid: Fludrocortisone Fludrocortisone 0.05-0.1 mg PO qd; 0.05-0.1 mg PO qd; some patients may only require alternate-day dosingsome patients may only require alternate-day dosing..

Page 63: Adrenocortical Disorders

Anesthetic considerationsAnesthetic considerations

Preoperative managementPreoperative management**ensure adequate replacement therapyensure adequate replacement therapy

**correct fluid and electrolytes disturbacescorrect fluid and electrolytes disturbaces

Page 64: Adrenocortical Disorders

**for all patients who have received potentially for all patients who have received potentially suppressive doses of steroids, the daily suppressive doses of steroids, the daily equivalent of 5 mg of prednisone, by any route equivalent of 5 mg of prednisone, by any route of administration- topical, inhalational or oral-, of administration- topical, inhalational or oral-, for a period of more than 2 weeks any time in for a period of more than 2 weeks any time in the previous 12 months may be unable to the previous 12 months may be unable to

respond appropriately to surgical stressrespond appropriately to surgical stress . .

Page 65: Adrenocortical Disorders

Adults normally secrete 20mg of cortisol daily, Adults normally secrete 20mg of cortisol daily, this may increase to over 300 mg under maximal this may increase to over 300 mg under maximal stressstress..

- -100100 mg of hydrocortisone phosphate every 8 h mg of hydrocortisone phosphate every 8 h beginning the evening before or on the morning beginning the evening before or on the morning of surgeryof surgery..

Page 66: Adrenocortical Disorders

--an alternative low dose regimen, 25 mg of an alternative low dose regimen, 25 mg of hydrocortisone phosphate at the time of hydrocortisone phosphate at the time of induction followed by an infusion of 100 mg induction followed by an infusion of 100 mg during the subsequent 24 h, and this might be during the subsequent 24 h, and this might be appropriate for diabetic ptappropriate for diabetic pt..

Page 67: Adrenocortical Disorders

IntaoperativeIntaoperative ensure adequate fluidensure adequate fluid..

PostoperativePostoperativeContinue the stress dose of steroids to gard Continue the stress dose of steroids to gard

against acute adrenal crisisagainst acute adrenal crisis..

Page 68: Adrenocortical Disorders

1111 - -beta Hydroxylase Deficiencybeta Hydroxylase DeficiencyCongenital adrenal hyperplasia )CAH( is a Congenital adrenal hyperplasia )CAH( is a

general term used to describe a group of general term used to describe a group of inherited disorders in which a defect in cortisol inherited disorders in which a defect in cortisol biosynthesis is present with consequent biosynthesis is present with consequent overproduction of )ACTH( and secondary overproduction of )ACTH( and secondary adrenal hyperplasia as a consequenceadrenal hyperplasia as a consequence..

CausesCausesAn autosomal recessive diseaseAn autosomal recessive disease..

Page 69: Adrenocortical Disorders

Patients with 11-beta-hydroxylase deficiency Patients with 11-beta-hydroxylase deficiency present with features of androgen excess, present with features of androgen excess, including masculinization of female newborns including masculinization of female newborns

and precocious puberty in male childrenand precocious puberty in male children . .

Approximately two thirds of patients also have Approximately two thirds of patients also have hypertension, which may or may not be hypertension, which may or may not be associated with mineralocorticoid excess, associated with mineralocorticoid excess, hypokalemia, hyperhypokalemia, hypernatremia natremia and metabolic and metabolic

alkalosisalkalosis . .

Page 70: Adrenocortical Disorders

The hypertension is initially responsive to The hypertension is initially responsive to glucocorticoid replacement, but it may become a glucocorticoid replacement, but it may become a chronic condition subsequently requiring chronic condition subsequently requiring standard antihypertensive therapystandard antihypertensive therapy..

Page 71: Adrenocortical Disorders

Addison Disease and PregnancyAddison Disease and Pregnancy

--Before glucocorticoid replacement therapy Before glucocorticoid replacement therapy became available, pregnancy in patients with became available, pregnancy in patients with adrenal insufficiency was associated with a adrenal insufficiency was associated with a

maternal mortality rate of 35-45%maternal mortality rate of 35-45% . .

--The usual glucocorticoid and mineralocorticoid The usual glucocorticoid and mineralocorticoid replacement dosages are continued throughout replacement dosages are continued throughout pregnancy. Some patients may require slightly pregnancy. Some patients may require slightly

more glucocorticoid in the third trimestermore glucocorticoid in the third trimester . .

Page 72: Adrenocortical Disorders

During labor, adequate saline hydration and 25 During labor, adequate saline hydration and 25 mg of intravenous cortisol )ie, hydrocortisone mg of intravenous cortisol )ie, hydrocortisone sodium succinate( should be administered every sodium succinate( should be administered every

6 hours6 hours . .

At the time of delivery or if the labor is At the time of delivery or if the labor is prolonged, high-dose parenteral hydrocortisone prolonged, high-dose parenteral hydrocortisone should be administered )100 mg q6h or as a should be administered )100 mg q6h or as a

continuous infusion(continuous infusion( . .

Page 73: Adrenocortical Disorders

After delivery, the dosage can be quickly After delivery, the dosage can be quickly tapered to a maintenance dose in 3 daystapered to a maintenance dose in 3 days..

Page 74: Adrenocortical Disorders

Cushing Syndrome and PregnancyCushing Syndrome and PregnancyThe risk of maternal morbidity and a poor fetal The risk of maternal morbidity and a poor fetal

outcome is significant when Cushing syndrome outcome is significant when Cushing syndrome coexists with pregnancycoexists with pregnancy . .

Maternal hypertension may antedate the Maternal hypertension may antedate the pregnancy but becomes worse in two thirds of pregnancy but becomes worse in two thirds of patientspatients..

Page 75: Adrenocortical Disorders

Preeclampsia or pregnancy-induced Preeclampsia or pregnancy-induced hypertension is noted in approximately 10% of hypertension is noted in approximately 10% of patientspatients..

Gestational DM occurs in approximately one thirdGestational DM occurs in approximately one third..

Congestive heart failure associated with severe Congestive heart failure associated with severe hypertension occurs in 10%hypertension occurs in 10%..

Page 76: Adrenocortical Disorders

Wound breakdown after surgery is possibleWound breakdown after surgery is possible . .

Severe proximal myopathy and mental problems Severe proximal myopathy and mental problems ranging from emotional lability to profoundranging from emotional lability to profound

psychosis should be added to the list of medical psychosis should be added to the list of medical problems that may occurproblems that may occur..

Page 77: Adrenocortical Disorders

Primary Hyperaldosteronism and PregnancyPrimary Hyperaldosteronism and PregnancyPatients present with hypertension, Patients present with hypertension,

hypokalemia, and elevated urine potassium hypokalemia, and elevated urine potassium levelslevels..

The goals of medical therapy should be The goals of medical therapy should be adequate control of blood pressure and adequate control of blood pressure and replacement of potassiumreplacement of potassium

Page 78: Adrenocortical Disorders

spironolactone and angiotensin-converting spironolactone and angiotensin-converting enzyme inhibitors, are contraindicated in enzyme inhibitors, are contraindicated in

patients who are pregnantpatients who are pregnant . .

Methyldopa, beta-blockers, and calcium channel Methyldopa, beta-blockers, and calcium channel blockers have been used with variable outcomesblockers have been used with variable outcomes

Page 79: Adrenocortical Disorders